20 articles
67-person study tested whether whole foods diet and stress reduction could lengthen protective chromosome caps in pain sufferers.
Researchers used retinal imaging to detect brain amyloid and tested whether telomerase activation could reduce Alzheimer's markers.
Study examines whether CPAP therapy for sleep apnea can prevent telomere shortening and reduce cellular aging markers.
Ten-week trial examined how intermittent fasting affects aging markers and whether antioxidant supplements interfere with benefits.
A completed RCT from the University of Copenhagen tests whether aerobic exercise, time-restricted feeding, or NR supplementation best improves biological aging markers in healthy older adults.
A 10-week supervised strength program targets chronic inflammation and self-efficacy in long-term allogeneic HCT survivors.
UCSF study tests whether stress-reduction classes can reverse biological markers of cellular aging in overwhelmed caregivers.
UCSF study examines whether brief meditation intervention can improve biological markers of cellular stress and aging in both novice and experienced practitioners.
FDA-approved transplant drug tested in 70-95 year olds to combat age-related immune decline and improve longevity markers.
Chinese researchers tested nucleotide supplements against aging markers in 122 participants over 4 months with promising early results.
Wake Forest researchers compared caloric restriction and time-restricted eating in 90 older adults over nine months.
Polish study examines whether weight loss surgery can turn back the molecular clock by measuring telomere length changes over 24 months.
Researchers analyzed epigenetic changes in 124 Israeli centenarians to understand the molecular basis of exceptional longevity.
Six-month trial examines whether metformin treatment can improve telomere length and longevity gene expression in prediabetic individuals.
Intensive vipassana meditation retreat showed measurable improvements in biological markers linked to aging and inflammation.
Small trial tests whether rapamycin, an FDA-approved drug, can improve heart function and immune response in people aged 70-95.
Researchers tested sirolimus, metformin, and diclofenac as topical skin treatments to target aging pathways in healthy volunteers.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
Researchers explored whether cancer-derived cell-free DNA and telomere maintenance mutations could serve as early warning biomarkers in soft tissue sarcoma patients.
German researchers tested whether 4g daily taurine could slow aging processes in adults 55-75 over 6 months of supplementation.
